Fennec Pharmaceuticals (FENC) Total Debt Growth (3y) (2013 - 2017)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 402.14% |
| Sep 30, 2017 | -52.58% |
| Jun 30, 2017 | -67.10% |
| Mar 31, 2017 | -76.57% |
| Dec 31, 2016 | -77.41% |
| Sep 30, 2016 | -79.64% |
| Jun 30, 2016 | -72.45% |
| Mar 31, 2016 | -84.37% |
| Dec 31, 2015 | -76.89% |
| Sep 30, 2015 | -57.87% |
| Jun 30, 2015 | -34.63% |
| Mar 31, 2015 | -26.53% |
| Dec 31, 2014 | -36.19% |
| Sep 30, 2014 | -28.23% |
| Jun 30, 2014 | -9.69% |
| Dec 31, 2013 | -35.05% |